本文選題：肺癌 + 回顧性分析　； 參考：《廣西中醫(yī)藥大學(xué)》2017年碩士論文

【摘要】：目的:回顧性研究310例住院病人的臨床治料,了解肺癌的一般臨床特征及治療療效情況,為提高肺癌的臨床治療效果提供相對科學(xué)的依據(jù)。方法:回顧性總結(jié)分析柳州市中醫(yī)院2007年至2016年肺癌患者病例資料,嚴格按照納入及排除標準篩選病例,對符合條件的病例資料采用SPSS17.0軟件進行統(tǒng)計分析。結(jié)果:(1)本次研究310例肺癌中位發(fā)病年齡為67歲,(2)漢族、壯族、其他民族組間前后5年發(fā)病人數(shù)比較,無統(tǒng)計學(xué)意義(P0.05)。(3)前后5年腺癌與鱗癌發(fā)病人數(shù)發(fā)生變化(P0.05)。(4)肺鱗癌與其他幾種病理類型肺部感染存在差異(P0.05)。(5)肺腺癌與肺鱗癌中醫(yī)證型不同(P0.05)。(6)左右兩肺原發(fā)性肺癌中醫(yī)證型比較,無統(tǒng)計學(xué)意義(P0.05)。(7)肺癌解剖分型及肺癌中醫(yī)證型的性別比較,無統(tǒng)計學(xué)意義(P0.05)。(8)化療結(jié)合中成藥及中藥湯劑比化療結(jié)合中成藥在改善中醫(yī)癥候積分、提高卡氏評分、降低CEA、控制瘤體大小,減輕惡心嘔吐程度療效更好(P0.05)。結(jié)論:(1)高齡、吸煙仍是肺癌發(fā)生的重要因素。(2)不同民族間前后5年肺癌發(fā)病情況可能不存在差異。(3)肺癌不同病理類型構(gòu)成比在發(fā)生變化。(4)不同病理類型的中醫(yī)證型及肺部感染情況存在差異。(5)因性別不同肺癌的中醫(yī)證型與解剖分型也不同。(6)化療結(jié)合中成藥及中藥湯劑在治療肺癌上能取得良好的臨床療效。
[Abstract]:Objective: to retrospectively study the clinical materials of 310 inpatients with lung cancer, to understand the general clinical characteristics and therapeutic efficacy of lung cancer, and to provide a scientific basis for improving the clinical treatment effect of lung cancer. Methods: the data of lung cancer patients in Liuzhou traditional Chinese Medicine Hospital from 2007 to 2016 were analyzed retrospectively. The cases were screened according to the criteria of inclusion and exclusion. SPSS 17.0 software was used to analyze the data of eligible cases. Results: (1) the median age of lung cancer in this study was 67 years old. There was no significant difference (P0.05). (3) before and after 5 years of changes in the incidence of adenocarcinoma and squamous cell carcinoma (P0.05). (4) lung squamous cell carcinoma and several other pathological types of pulmonary infection differences (P0.05). (5) lung adenocarcinoma and lung squamous cell carcinoma TCM syndrome type difference (P0.05). (6) about two types of primary lung cancer syndrome comparison. There was no significant difference (P0.05). (7) in the anatomical classification of lung cancer and gender comparison of TCM syndrome type of lung cancer. There was no statistical significance (P0.05). (8) that chemotherapy combined with traditional Chinese medicine and traditional Chinese medicine decoction could improve the score of TCM symptoms and improve the score of cardinal score. Reduce CEA, control tumor size, reduce nausea and vomiting better (P0.05). Conclusion: (1) aged, Smoking is still an important factor in the occurrence of lung cancer. (2) there may be no difference in the incidence of lung cancer between different nationalities before and after 5 years. (3) the composition ratio of different pathological types of lung cancer is changing. (4) TCM syndromes and pulmonary infection of different pathological types are changing. (5) the TCM syndromes and anatomic types of lung cancer are different according to sex. (6) chemotherapy combined with traditional Chinese medicine and traditional Chinese medicine decoction can obtain good clinical effect in the treatment of lung cancer.
【學(xué)位授予單位】：廣西中醫(yī)藥大學(xué)
【學(xué)位級別】：碩士
【學(xué)位授予年份】：2017
【分類號】：R734.2

【參考文獻】

相關(guān)期刊論文 前10條

1 張銀萍;崔焱;錢志慧;金宇;潘志娟;朱金星;陳長芳;言克莉;劉扣英;;肺癌化療患者PICC相關(guān)上肢深靜脈血栓的危險因素分析[J];中華護理雜志;2016年04期

2 張仁鋒;張巖;溫豐標;吳愷;趙松;;6,058例肺癌患者病理類型和臨床流行病學(xué)特征的分析[J];中國肺癌雜志;2016年03期

3 隋麗麗;葉斯斯;白莉;;90例肺癌合并下肢靜脈血栓形成的臨床特征分析[J];解放軍醫(yī)學(xué)院學(xué)報;2016年06期

4 張麗輝;王兵;李振宇;;扶正固本散治療肺癌術(shù)后患者31例[J];光明中醫(yī);2016年05期

5 苗婷婷;;黃煌運用薯蕷丸治療化療后肺癌的臨床經(jīng)驗[J];南京中醫(yī)藥大學(xué)學(xué)報;2016年02期

6 于海艷;劉興隆;沈濤;祝捷;楊露;;歸(引)肺經(jīng)藥與肺癌靶向治療的探討[J];時珍國醫(yī)國藥;2016年01期

7 張譽華;沈洋;龍麟;楊婕;孫韜;;養(yǎng)肺消疹方治療肺癌靶向藥物相關(guān)性皮疹的臨床觀察[J];中華中醫(yī)藥雜志;2016年01期

8 王峰;張大鵬;夏鑫華;潘俊輝;;邱志楠教授治療肺癌經(jīng)驗拾萃[J];中國中醫(yī)藥現(xiàn)代遠程教育;2015年20期

9 張文周;杜娟;;艾迪注射液輔助治療中晚期肺癌近期及遠期療效觀察[J];中國醫(yī)院藥學(xué)雜志;2015年20期

10 謝襯梨;趙一菊;蔡良真;梁秋亭;;肺癌合并靜脈血栓患者的臨床特點及預(yù)后分析[J];中國現(xiàn)代藥物應(yīng)用;2015年15期

相關(guān)碩士學(xué)位論文 前1條

1 孫麗娥;王俊顯老師學(xué)術(shù)經(jīng)驗總結(jié)及癌癥治療方藥規(guī)律的臨床研究[D];北京中醫(yī)藥大學(xué);2013年

，

本文編號：2109754